Nuo Therapeutics, Inc. (AURX)

R&D to Revenue

0.00%

Fiscal year · Period ending:

AURX logo

AURX R&D to Revenue

Latest reported0.00%
AURX FY R&D/Revenue (0.00% → 0.00%)
High-resolution chart · PNG

AURX r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
0%
0%
0%
0%
0%
0%
123.949%
42.0396%
184.2221%
66.38%
22.1598%
33.8001%
32.8256%
32.0557%
1.3543%
10.6272%
11.0102%
6.9695%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.